top of page
CGTI green logo.png
CGTI.png
GBX ICON PURPLE_edited_edited.png

Uwe Gottschalk

Uwe Gottschalk is Operating Partner at Keensight Capital - Former CSO of Lonza

Dr. Uwe Gottschalk is Operating Partner at Keensight Capital. formerly CSO of Lonza Group, a Swiss multinational CMO, with major facilities in Europe, North America and Asia. Prior to Lonza, Uwe was Group Vice President of Sartorius AG, and earlier, Head of GMP Purification at Bayer
Health Care.Chief Scientific Officer

Share
  • LinkedIn
  • Youtube
  • X
  • Instagram
How we drive innovation
MEETINGS
MEMBERS
Speakers

Jesse McCool

CSO of Bionova Scientific

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Thomas Potgieter

SVP of Global Cell Therapy Development & Operations at Bristol Myers Squibb

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Angela Vollstedt, PhD MBA

Director Global Cell & Gene Therapies Portfolio Management at Novartis

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Paolo Martini

Chief Research & Development Officer at ReAlta Life Sciences former CSO at Moderna

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Gwendolyn Binder PhD

President, Science and Technology at Cabaletta Bio

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Warner Biddle

CEO at Kyverna Therapeutics former interim CEO at Kite a Gilead Company

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS

Jens Vogel

Jens H. Vogel
President & COO of Mirai Bio - Former CEO of BI Fremont & Global Head of Biotech at Bayer Pharmaceuticals

Jens H. Vogel, SVP & Global Head of Biotech at Bayer is an advisor of GBX EVENTS
bottom of page